Maastricht University Medical Center: clinical-trial pipeline
Maastricht University Medical Center is the sponsor of 852 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 98 are not yet finished and 2 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 749 |
| Phase 4 | 43 |
| Phase 3 | 22 |
| Phase 2 | 20 |
| Phase 1/2 | 6 |
| Early phase 1 | 5 |
| Phase 1 | 4 |
| Phase 2/3 | 3 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 523 |
| Unknown | 181 |
| Recruiting | 62 |
| Terminated | 38 |
| Not yet recruiting | 19 |
| Active, not recruiting | 17 |
| Withdrawn or not authorised | 12 |
Condition areas
| Area | Trials |
|---|---|
| Metabolic and endocrine (diabetes, obesity) | 165 |
| Cardiovascular | 151 |
| Oncology | 101 |
| Gastroenterology and liver | 79 |
| Rare and genetic diseases | 73 |
| Musculoskeletal | 67 |
| Neurology | 56 |
| Respiratory | 44 |
| Infectious disease and vaccines | 32 |
| Immunology and rheumatology | 31 |
| Nephrology and urology | 29 |
| Women's health and obstetrics | 21 |
Countries
| Country | Trials |
|---|---|
| Netherlands | 804 |
| Belgium | 16 |
| Italy | 11 |
| United Kingdom | 9 |
| Germany | 8 |
| Spain | 5 |
| France | 4 |
| Austria | 3 |
| Norway | 3 |
| Switzerland | 2 |
| Hungary | 2 |
| Israel | 2 |
| Portugal | 2 |
| Russia | 2 |
| Sweden | 2 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-23 | New trial posted | Feasibility of Physical Prehabilitation for High-Risk Patients Undergoing Cardiac Surgery… |
| 2026-09-04 | New trial posted | Magnetic Brain Stimulation in Small Fiber Neuropathy |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT04954599 | Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI | Phase 1/2 | Active, not recruiting | Belgium, Spain, Netherlands |
| NCT06499415 | Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Kera… | Phase 4 | Active, not recruiting | Netherlands |
| NCT06335069 | 18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer. | Phase 2 | Recruiting | Netherlands |
| NCT03917303 | Control Crohn Safe Trial | Phase 4 | Active, not recruiting | Netherlands |
| NCT06401824 | Sacituzumab Govitecan and Bevacizumab for NSCLC Brain Metastases | Phase 2 | Recruiting | Netherlands |
| NCT07485452 | Boosting Osimertinib Blood Brain Barrier Penetration | Phase 2 | Recruiting | Netherlands |
| NCT07402343 | Tarlatamab for SCLC Brain Metastases | Phase 2 | Recruiting | Netherlands |
| NCT07752225 | Long-term Effects of Avocado Consumption on Health in Pre-diabetic Individuals | Not applicable | Not yet recruiting | Netherlands |
| NCT07547176 | Amino Acid Oxidation of Whole-Food Protein: a Dose-Response Crossover Trial in Young Adults | Not applicable | Recruiting | Netherlands |
| NCT06330350 | Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling | Not applicable | Recruiting | Netherlands |
| NCT06700187 | Frequency of Interrupting Sitting and Cognitive Function | Not applicable | Recruiting | Netherlands |
| NCT02422238 | Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease | Not applicable | Recruiting | Netherlands |
| NCT03983603 | Plant Stanol Esters and Preventing Asthma Symptoms | Not applicable | Recruiting | Netherlands |
| NCT03807310 | Targeted Nutrient Supplement in COPD (NUTRECOVER-trial) | Not applicable | Active, not recruiting | Netherlands |
| NCT04918745 | VertiGO! - Get up and GO! With the Vestibular Implant | Not applicable | Active, not recruiting | Netherlands |
| NCT07280819 | Nutritional and Physical Intervention During Bed Rest | Not applicable | Not yet recruiting | Netherlands |
| NCT06746805 | The Effect of Acute Ketone Monoester Supplementation on Glucose Oxidation During Exercise | Not applicable | Recruiting | Netherlands |
| NCT07142317 | GPR146 and Cholesterol Metabolism | Not applicable | Not yet recruiting | Netherlands |
| NCT07501780 | Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice | Not applicable | Recruiting | Netherlands |
| NCT05640089 | FMRI-neurofeedback in Depression | Not applicable | Recruiting | Netherlands |
| NCT06783075 | Milk Vs Wheat Protein Intake to Maximize Whole-body Protein Synthesis Rates in Healthy Older Adults | Not applicable | Not yet recruiting | Netherlands |
| NCT06766006 | ECMO LEft Ventricle UNloading Strategy | Not applicable | Recruiting | Netherlands |
| NCT05987579 | Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp | Not applicable | Active, not recruiting | Netherlands |
| NCT07556029 | Optimal Protein Intake to Maximize Whole-Body Protein Balance in Healthy Adults | Not applicable | Not yet recruiting | Netherlands |
| NCT06046703 | Diet Quality of Pregnant Women With a Strict Plant-based Diet Versus an Omnivorous Diet | Not applicable | Not yet recruiting |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Maastricht University Medical Center clinical trials: 98 open, 25 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/maastricht-university-medical-center/, data as of 2026-10-25.